Lingyun Sun
- Immunology top 5%
- Rheumatology top 2%
- Molecular Biology
- Pharmaceutical Science top 2%
- Epidemiology
- Topics
- Systemic Lupus Erythematosus Research (26 papers)Rheumatoid Arthritis Research and Therapies (16 papers)Salivary Gland Disorders and Functions (11 papers)
- Journals
- SHILAP Revista de lepidopterologíaEnvironmental Science & TechnologyPLoS ONE
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Lingyun Sun
92 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Immunology 476
- Rheumatology 448
- Molecular Biology 447
- Pharmaceutical Science 238
- Epidemiology 225
Countries citing papers authored by Lingyun Sun
This map shows the geographic impact of Lingyun Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyun Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyun Sun more than expected).
Fields of papers citing papers by Lingyun Sun
This network shows the impact of papers produced by Lingyun Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyun Sun. The network helps show where Lingyun Sun may publish in the future.
Co-authorship network of co-authors of Lingyun Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Lingyun Sun. A scholar is included among the top collaborators of Lingyun Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyun Sun. Lingyun Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 14 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 37 | |
| 7 | 2 | |
| 8 | 31 | |
| 9 | 65 | |
| 10 | 43 | |
| 11 | 47 | |
| 12 | 4 | |
| 13 | 32 | |
| 14 | 80 | |
| 15 | 43 | |
| 16 | 63 | |
| 17 | Artesunate relieves lupus nephritis by inhibiting the expression of ICAM-1 | 4 |
| 18 | 98 | |
| 19 | 30 | |
| 20 | Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial | 7 |
About Lingyun Sun
Lingyun Sun is a scholar working on Rheumatology, Immunology and Pharmaceutical Science, having authored 96 papers that have together received 1.8k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (26 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Salivary Gland Disorders and Functions (11 papers). The work is most often cited by research in Pharmaceutical Science (238 citations), Rheumatology (448 citations) and Rehabilitation (195 citations). Lingyun Sun has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Yuanjin Zhao, Xiaoxuan Zhang, Jingjing Gan, Wenjuan Ma, Weilin Liu, Lu Fan, Yuxiao Liu, Guopu Chen, Xuebing Feng and Genhong Yao. Their work appears in journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.